Biogen (BIIB)

Operating Cash Flow (Statement)

$448.90M

Quarterly · Period ending: · USD

BIIB logo

BIIB Operating Cash Flow (Statement)

Latest reported$448.90M
BIIB Quarterly Cash from Operations (-$200.00K → $448.90M)
High-resolution chart · PNG

BIIB operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
82,865,000
89,354,000
174,832,000
76,980,000
96,399,000
17,728,000
109,488,000
71,400,000
61,600,000
29,800,000
42,045,000
57,300,000
26,200,000
42,300,000
8,232,000
50,200,000
13,300,000
25,900,000
52,139,000
10,400,000
-7,400,000
-8,600,000
10,549,000
1,500,000
-3,400,000
800,000
-6,514,000
9,500,000
-1,800,000
33,700,000
8,200,000
8,700,000
14,000,000
16,700,000
28,500,000
11,400,000
-1,600,000
4,800,000
3,600,000
-800,000
400,000
2,700,000
3,700,000
2,600,000
6,100,000
-1,700,000
-200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.